RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BIO-Key International Stock

BIO-Key International Equity 2024

BIO-Key International Equity

1.06 M USD

Ticker

BKYI

ISIN

US09060C4087

WKN

A2QJDQ

In 2024, BIO-Key International's equity was 1.06 M USD, a -79.93% increase from the 5.3 M USD equity in the previous year.

BIO-Key International Aktienanalyse

What does BIO-Key International do?

BIO-Key International Inc. is a company specializing in biometric authentication and security solutions. It was founded in 1993 as a biometric research laboratory and has since become a leading provider of biometric authentication and security solutions worldwide. The company's business model consists of developing and selling biometric authentication and security solutions. It offers a wide range of products for various industries and customers, including businesses, government agencies, and the military. Some of its products include fingerprint-based authentication, facial recognition, iris scanner technologies, and software solutions such as ID Director. BIO-Key has expanded its offerings to include biometric-based hardware products such as fingerprint scanners for kiosks and ATMs, as well as biometric access control systems for offices and buildings. The company also specializes in Identity and Access Management (IAM) solutions. It is headquartered in Wall, New Jersey, operates offices in Europe and other continents, and is listed on the American stock exchange. Due to its technical capabilities, innovation, and market-oriented approach, BIO-Key is well-positioned to continue playing a leading role in the field of biometric authentication and security solutions in the future. BIO-Key International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing BIO-Key International's Equity

BIO-Key International's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding BIO-Key International's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating BIO-Key International's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

BIO-Key International's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in BIO-Key International’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about BIO-Key International stock

What is the equity of BIO-Key International this year?

BIO-Key International has equity of 1.06 M USD this year.

What was the equity of BIO-Key International compared to the previous year?

The equity of BIO-Key International has increased/decreased by -79.93% decreased compared to the previous year.

What impact does a high equity have on investors of BIO-Key International?

A high equity is advantageous for investors of BIO-Key International as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of BIO-Key International?

A low equity can be a risk for investors of BIO-Key International, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of BIO-Key International affect the company?

An increase in equity of BIO-Key International can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of BIO-Key International affect the company?

A reduction in equity of BIO-Key International can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of BIO-Key International?

Some factors that can affect the equity of BIO-Key International include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of BIO-Key International so important for investors?

The equity of BIO-Key International is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can BIO-Key International take to change the equity?

To change equity, BIO-Key International can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does BIO-Key International pay?

Over the past 12 months, BIO-Key International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BIO-Key International is expected to pay a dividend of 0 USD.

What is the dividend yield of BIO-Key International?

The current dividend yield of BIO-Key International is .

When does BIO-Key International pay dividends?

BIO-Key International pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BIO-Key International?

BIO-Key International paid dividends every year for the past 0 years.

What is the dividend of BIO-Key International?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BIO-Key International located?

BIO-Key International is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von BIO-Key International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BIO-Key International from 12/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did BIO-Key International pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of BIO-Key International in the year 2023?

In the year 2023, BIO-Key International distributed 0 USD as dividends.

In which currency does BIO-Key International pay out the dividend?

The dividends of BIO-Key International are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BIO-Key International

Our stock analysis for BIO-Key International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BIO-Key International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.